Healthcare & Pharmaceuticals
🟢 SERP-Grounded (Light Telemetry)
WIL Research
Programmatic AI Search & Model Visibility Audit
Share of Model (SOM)The percentage of time frontier AI models (ChatGPT, Claude, Gemini) recommend this brand for high-intent category queries.
10.0%
-3.0% 30-Day MomentumThe rolling 30-day change in algorithmic Share of Model. Positive momentum indicates increasing AI mindshare.
🧠 Neural Valency:VulnerableThe contextual sentiment of the AI's recommendation. 'Dominant' implies strong conviction, while 'Vulnerable' implies the model heavily conditions its recommendation.
Algorithmic Threat Detection
Primary Competitor Threat
Eurofins
Competitor Displacement Rate
25.0%
Competitors are displacing WIL Research in 25.0% of high-intent buyer queries.The frequency at which AI models actively suggest a competitor as a superior alternative to this brand.
Algorithmic Rationale: As a Contract Research Organization (CRO), WIL Research (now part of Inotiv) is likely being displaced by larger, more comprehensive CROs offering a wider range of services, especially in drug discovery and development. Competitors' broader capabilities and market presence are key factors.
Missing AI Citations:High-authority domains (e.g., Reddit, G2) that models cite to justify recommending competitors, where this brand currently lacks presence.
[inotivco.com][labcorpdrugdev.com][pks.com]⚠️ Identified Vulnerability:Service Breadth
Primary Threat Identified:Eurofins
Target Persona:Pharmaceutical Companies Seeking CRO Services
🚨 Threat Velocity:7/10An algorithmic urgency score (1-10) indicating how rapidly competitors are capturing this brand's historical AI search share.
Unlock Full Threat Report (30 Free Credits)